Skip to main content
Fig. 3 | BMC Geriatrics

Fig. 3

From: Effect of choline alfoscerate in older adult patients with dementia: an observational study from the claims data of national health insurance

Fig. 3

Survival curves in landmark analysis with the x-axis of time (year) and the y-axis of survival probability (%), comparing (I) progression-free interval and (II) overall survival between choline alfoscerate-exposed (blue (dark gray) line) and nonexposed (orange (light gray) line) groups at different landmark timepoints of (a) 360 days, (b) 720 days, and (c) 1080 days

Back to article page

BMC Geriatrics

ISSN: 1471-2318

Contact us